We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Cisbio International Announces Launch of HTRF® KinEASE™ TK at SBS
Product News

Cisbio International Announces Launch of HTRF® KinEASE™ TK at SBS

Cisbio International Announces Launch of HTRF® KinEASE™ TK at SBS
Product News

Cisbio International Announces Launch of HTRF® KinEASE™ TK at SBS


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Cisbio International Announces Launch of HTRF® KinEASE™ TK at SBS"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Cisbio international has announced the launch of HTRF® KinEASE™ TK at the SBS Conference in Montreal, Canada.

HTRF® KinEASE™ TK is a universal assay for high throughput screening of Tyrosine (Tyr) kinases, major targets in drug discovery, in particular in oncology research.

With the development of this tool, Cisbio now offers its customers the ability to use a reliable kinase screening platform based on one technology to address a broad range of kinase targets.

HTRF® KinEASE™ TK combines a peptide substrate called S4 and a single monoclonal antibody with Cisbio’s HTRF® (homogeneous time resolved fluorescence) technology, a technology for the detection of molecular interactions of proteins in vitro.

HTRF® KinEASE™ TK limits assay development time and is miniaturizable and flexible, meaning the assay can be performed under a wide range of kinase assay conditions, for instance with low consumption of enzyme or with any ATP concentration.

HTRF® KinEASE™ TK is the fifth kit in the HTRF® KinEASE™ platform, developed in collaboration with Millipore (Upstate) for profiling and HTS of Serine/Threonine (Ser/Thr) kinases.

Launched in March 2006, the platform consists of four kits combining 3 biotinylated substrates, S1, S2 and S3, with a monoclonal antibody and HTRF®. Since this new Tyr kinase assay is based on the same monoclonal antibody principle as HTRF® KinEASE™, the implementation of the assay by Cisbio’s existing HTRF® KinEASE™ customers is very straightforward.

Advertisement